Guidance Document - Comparative...
Dataset description:
To ensure that sponsors of new drug submissions have the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug...
Source: Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 20, 2025 |
| Metadata last updated | October 20, 2025 |
| Created | October 20, 2025 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | 9a4b0b3b-d7c1-4d20-a3eb-beccf1621b2b |
| Package id | db3acd6d-614d-4942-b4a8-776bae4999b7 |
| Position | 1 |
| State | active |